Abbott, CamDiab and Ypsomed to develop automated insulin delivery system
The solution will incorporate Abbott’s FreeStyle Libre 3 sensor, CamDiab's CamAPS FX algorithm and Ypsomed’s mylife YpsoPump.

The solution will incorporate Abbott’s FreeStyle Libre 3 sensor, CamDiab's CamAPS FX algorithm and Ypsomed’s mylife YpsoPump.
The merged company could become a leader in offering various neurovascular technologies and solutions globally.
The system comprises a Passio catheter, handheld control unit and disposable collection kit.
The test uses cfDNA to measure the damage that Covid-19 inflicts on organs, cells and tissues.
During second half of 2021, deals relating to China's socioeconomic impact accounted for 14.5% of all deals taking place in…
ByThe platform will enable the expansion of various gene panels that are available to analyse solid tumours.
Recombinant proteins are used in the development and manufacturing of cell and gene therapies.
The acquisition of OrthogenRx’s products will complement Avanos’ COOLIEF cooled RF treatment portfolio.